Dr. Ashraf Fawzy, MD, MPH

Dr. Fawzy practices at Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System.

Dr. Fawzy's NPI, 1083957013, was assigned on March 27, 2013. Dr. Fawzy holds Maryland license D82387.

Dr. Fawzy's primary practice is Johns Hopkins Bayview Medical Center, at 4940 Eastern Avenue, Baltimore, MD 21224 in Baltimore City. The practice phone is (410) 550-0123.

Dr. Fawzy's primary practice is Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System. Dr. Fawzy is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fawzy practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Fawzy's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Fawzy is licensed in Maryland.

CMS data shows 209 Medicare services from Dr. Fawzy across 7 procedure codes in 2024, for 90 Medicare patients. Medicare paid $18,576 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 90 Medicare patients who saw Dr. Fawzy in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 3.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fawzy's median patient age at 73, with 62% women.

In 2024, Dr. Fawzy wrote 278 Medicare Part D claims for 37 patients. 23% of them were for generic drugs. CMS names the drug for 181 of them, across 6 drugs with 11 or more claims each, at $76,729 in total drug cost. In 2023, CMS named 160 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Fawzy for performance year 2024, reported as part of a group. CMS lists Dr. Fawzy as offering telehealth.

Dmand AI links 59 papers to Dr. Fawzy, published from 2011 to 2025. 2021 was the busiest year, with 8. The most frequent topics are Pulmonary Disease, Chronic Obstructive, Forced Expiratory Volume and Oximetry. Dr. Fawzy has published most often in Chronic Obstr Pulm Dis. Dr. Fawzy's most frequent co-authors are Meredith Christine McCormack, MD, Robert Wise, MD and Aparna Balasubramanian.

CMS Open Payments shows 3 general payments to Dr. Fawzy from 3 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 95% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $3,000.